Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Andersen-Tawil syndrome laboratory findings
Introduction
Overview
Overview
Laboratory findings consistent with the diagnosis of Andersen-Tawil syndrome (ATS) include serum potassium levels. Some patients with Andersen-Tawil syndrome (ATS) may have elevated/reduced concentration of serum potassium levels, which is usually suggestive of Andersen-Tawil syndrome (ATS).
Laboratory Findings
Laboratory Findings
- There are no diagnostic laboratory findings associated with Andersen-Tawil syndrome (ATS).
- An elevated/reduced concentration of serum potassium levels is consistent in Andersen-Tawil syndrome (ATS).[1]
- Patients with Andersen-Tawil syndrome (ATS) may experience weakness when the potassium levels in the blood drops to low which suggests the name hypokalemic periodic paralysis.[2][3]
- Weakness may also occurs in patients with Andersen-Tawil syndrome (ATS) when the potassium levels are even normal but the weakness may be triggered by exercise, cold, or even sometimes menstruation.
- Thyroid hormones such as thyroid-stimulating hormone (TSH), T4, and T3 levels should be checked due to thyrotoxic periodic paralysis can also present with muscle weakness and paralysis.[4][5][6]
References
References
- ↑ Sansone V, Tawil R (2007). “Management and treatment of Andersen-Tawil syndrome (ATS)”. Neurotherapeutics. 4 (2): 233–7. doi:10.1016/j.nurt.2007.01.005. PMID 17395133.
- ↑ Nguyen, Hoai-Linh; Pieper, Gerard H.; Wilders, Ronald (2013). “Andersen–Tawil syndrome: Clinical and molecular aspects”. International Journal of Cardiology. 170 (1): 1–16. doi:10.1016/j.ijcard.2013.10.010. ISSN 0167-5273.
- ↑ Nguyen HL, Pieper GH, Wilders R (2013). “Andersen-Tawil syndrome: clinical and molecular aspects”. Int J Cardiol. 170 (1): 1–16. doi:10.1016/j.ijcard.2013.10.010. PMID 24383070.
- ↑ Ryan DP, da Silva MR, Soong TW, Fontaine B, Donaldson MR, Kung AW; et al. (2010). “Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis”. Cell. 140 (1): 88–98. doi:10.1016/j.cell.2009.12.024. PMC 2885139. PMID 20074522.
- ↑ Munir I, Mehmood T, Islam K, Soni L, McFarlane SI (2019). “Thyrotoxic Periodic Paralysis with Sensory Deficits in Young African American Male: A Case Report and Literature Review”. Am J Med Case Rep. 7 (7): 138–142. doi:10.12691/ajmcr-7-7-5. PMC 6688769 Check
|pmc=value (help). PMID 31404457. - ↑ Rajpal A, Sood A (2019). “HYPOKALEMIC PERIODIC PARALYSIS IN A PATIENT WITH EUTHYROID GRAVES DISEASE AND CELIAC DISEASE”. AACE Clin Case Rep. 5 (1): e73–e76. doi:10.4158/ACCR-2018-0206. PMC 6876974 Check
|pmc=value (help). PMID 31967006.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]